通过考虑变异基质特异性和新型多态单体类型,改善了对CYP2D6催化药物代谢的预测
Inger Johansson1, Emmanouella M Xanthopoulou1, Yitian Zhou1,2
1Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Clinical pharmacology and therapeutics
|April 22, 2025
概括
酶CYP2D6的遗传变异显著影响药物代谢. 确定了新的多态单体类型,提高了对RISPERIDONE和DESMETHYLTAMOXIFEN等药物的预测准确度.
科学领域:
- 药物基因组学 药物基因组学
- 酶动力学 酶动力学
- 药物代谢药物代谢
背景情况:
- 细胞染色体P450 2D6 (CYP2D6) 酶对于大约25%的处方药物代谢至关重要.
- 药物反应的个体间变异性通常与CYP2D6遗传变异有关.
- 量化特定CYP2D6变异对药物代谢的精确影响仍然是一个挑战.
研究的目的:
- 量化特定遗传变异和新型多态单体对CYP2D6-介导药物代谢的影响.
- 分析CYP2D6基因型和表型与RISPERIDONE和DESMETHYLTAMOXIFEN代谢相关的情况.
- 提高基因预测模型对CYP2D6药物代谢的准确性.
主要方法:
- 在两个大型临床队列中分析患者的基因型和表型.
- 包括新型多态单质类型和CYP2D6变体 (CYP2D6.1,CYP2D6.2,CYP2D6.35) 的基质特异性差异.
- 在体内和体外 (表达模型) 评估酶动力学 (Kcat,基质亲和力,对接).
主要成果:
- 在CYP2D6.2和CYP2D6.35变体中,对Risperidone和Desmethyltamoxifen的代谢能力降低.
- 在CYP2D6*1,CYP2D6*2和CYP2D6*35背景上的新型多态单元型增加了CYP2D6活性30-40%.
- 结合这些发现,改善了德甲基塔莫西芬 (59%至71%) 和瑞斯佩里 (42%至46%) 的遗传预测准确度.
结论:
- CYP2D6.2和CYP2D6.35变体具有降低的代谢活性.
- 新的多态单体类型显著影响CYP2D6活性.
- 考虑到药物特异性相互作用和独特的单元类型,可以增强临床应用的药物基因组模型.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
34
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
34
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
104
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
104
Factors Affecting Drug Biotransformation: Biological
128
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
128
Analysis of Population Pharmacokinetic Data
241
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
241
Nonlinear Pharmacokinetics: Role of Transporters
41
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
41
Pharmacokinetic Models: Comparison and Selection Criterion
50
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
50


